Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Interest Expenses (2025)

Historic Interest Expenses for Iovance Biotherapeutics (IOVA) over the last 3 years, with Q3 2025 value amounting to $55.8 million.

  • Iovance Biotherapeutics' Interest Expenses changed N/A to $55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.8 million, marking a year-over-year change of. This contributed to the annual value of -$5660.0 for FY2014, which is 10127.27% down from last year.
  • According to the latest figures from Q3 2025, Iovance Biotherapeutics' Interest Expenses is $55.8 million.
  • Iovance Biotherapeutics' Interest Expenses' 5-year high stood at $55.8 million during Q3 2025, with a 5-year trough of $55.8 million in Q3 2025.